Our metabolic disease-derived human plasma is collected from rigorously consented donors diagnosed with metabolic disorders, including type 2 diabetes, non-alcoholic steatohepatitis (NASH), obesity-related metabolic dysfunction, and insulin resistance. This plasma provides a physiologically relevant matrix rich in disease-associated biomarkers, inflammatory cytokines, and metabolic factors, making it an essential tool for translational research and therapeutic development.
 
Ideal for studies on metabolic syndrome, insulin resistance mechanisms, biomarker discovery, and drug efficacy testing, this plasma supports a wide range of applications in metabolic disease modeling, diagnostic assay development, and therapeutic target validation.
 
Detailed donor information, including clinical background and metabolic profiles, is available upon request to support precise research needs. Custom cohort selection and plasma pooling options are also offered.